{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,7]],"date-time":"2026-07-07T00:18:44Z","timestamp":1783383524751,"version":"3.54.6"},"reference-count":66,"publisher":"Walter de Gruyter GmbH","issue":"2","funder":[{"DOI":"10.13039\/100007787","name":"National Research Centre","doi-asserted-by":"publisher","award":["11010131"],"award-info":[{"award-number":["11010131"]}],"id":[{"id":"10.13039\/100007787","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2023,6,15]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec id=\"j_jcim-2021-0479_abs_001\">\n                    <jats:title>Objectives<\/jats:title>\n                    <jats:p>Obesity, diabetes mellitus, insulin resistance (IR), and hypertriglyceridemia are common features observed in non-alcoholic fatty liver diseases (NAFLD). There is a critical medical necessity to find novel therapeutics that can halt the development of NAFLD.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"j_jcim-2021-0479_abs_002\">\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>\n                      <jats:italic>Bombax ceiba<\/jats:italic>\n                      Linn. leaf extract was prepared and its phytochemical profile was determined. Standard and high carbohydrate high-fat diets (HCHF) were prepared. Rats were fed HCHF for 18\u00a0weeks to induce a non-alcoholic fatty liver (NAFL) model. Forty male rats were divided into control,\n                      <jats:italic>B.\u00a0ceiba<\/jats:italic>\n                      Linn. leaf extract, NAFL, prophylactic, and treated groups. Serum fasting blood sugar (FBS), insulin, insulin resistance (HOMA-IR), cholesterol, high-density lipoprotein (HDL), triglycerides (TG), low density lipoprotein (LDL), alanine aminotransferase (ALT), aspartate aminotransferase (AST), intelectin-1 (ITLN1), p38 MAP kinase (MAPK), peroxisome proliferator-activated receptor alpha (PPAR-\u03b1), and interleukin-6 (IL-6) were evaluated.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"j_jcim-2021-0479_abs_003\">\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      Data obtained showed that HCHF-induced NAFL resulting in a significant increase in FBS, serum insulin, HOMA-IR, cholesterol, LDL, TG, ALT, AST, and IL-6 and a significant decrease in serum levels of HDL, ITLN1, p38 MAP kinase, and PPAR-\u03b1 compared to the control group. The analysis of\n                      <jats:italic>B.\u00a0ceiba<\/jats:italic>\n                      Linn. leaf extract showed high content of phenol compounds which may cause a significant decrease in the levels of FBS, insulin, HOMA-IR values, lipid profile, and levels of IL-6 while a significant increase in serum levels of LDL, ITLN1, p38 MAP kinase, and PPAR-\u03b1 compared to the NAFL group.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"j_jcim-2021-0479_abs_004\">\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>\n                      <jats:italic>B.\u00a0ceiba<\/jats:italic>\n                      Linn. Leaf extract is a highly protective and promising therapeutic agent against inflammation and oxidative stress in the NAFLD model induced by HCHF.\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.1515\/jcim-2021-0479","type":"journal-article","created":{"date-parts":[[2023,3,20]],"date-time":"2023-03-20T01:20:28Z","timestamp":1679275228000},"page":"343-352","source":"Crossref","is-referenced-by-count":6,"title":["<i>Bombax ceiba<\/i>\n                    Linn. leaf extract rich in phenolic compounds to mitigate non-alcoholic fatty liver-related complications in experimental model"],"prefix":"10.1515","volume":"20","author":[{"given":"Mona A.","family":"El-Bana","sequence":"first","affiliation":[{"name":"Department of Medical Biochemistry , Medical Research and Clinical Studies Institute, National Research Centre , Dokki , Giza , Egypt"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Magdi N.","family":"Ashour","sequence":"additional","affiliation":[{"name":"Department of Medical Biochemistry , Medical Research and Clinical Studies Institute, National Research Centre , Dokki , Giza , Egypt"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wafaa I.","family":"Rasheed","sequence":"additional","affiliation":[{"name":"Department of Medical Biochemistry , Medical Research and Clinical Studies Institute, National Research Centre , Dokki , Giza , Egypt"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yasser M.","family":"Diab","sequence":"additional","affiliation":[{"name":"Department of Biochemistry, Faculty of Agriculture , Fayoum University , Fayoum , Egypt"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6342-3180","authenticated-orcid":false,"given":"Dalia","family":"Medhat","sequence":"additional","affiliation":[{"name":"Department of Medical Biochemistry , Medical Research and Clinical Studies Institute, National Research Centre , Dokki , Giza , Egypt"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"374","published-online":{"date-parts":[[2023,3,21]]},"reference":[{"key":"2025121209140770569_j_jcim-2021-0479_ref_001","doi-asserted-by":"crossref","unstructured":"Benedict, M, Zhang, X. Non-alcoholic fatty liver disease: an expanded review. World J Hepatol 2017;9:715\u201332. https:\/\/doi.org\/10.4254\/wjh.v9.i16.715.","DOI":"10.4254\/wjh.v9.i16.715"},{"key":"2025121209140770569_j_jcim-2021-0479_ref_002","doi-asserted-by":"crossref","unstructured":"Lam, B, Younossi, ZM. Treatment options for nonalcoholic fatty liver disease. Therap Adv Gastroenterol 2010;3:121\u201337. https:\/\/doi.org\/10.1177\/1756283x09359964.","DOI":"10.1177\/1756283X09359964"},{"key":"2025121209140770569_j_jcim-2021-0479_ref_003","doi-asserted-by":"crossref","unstructured":"Sakaguchi, S, Takahashi, S, Sasaki, T, Kumagai, T, Nagata, K. Progression of alcoholic and non-alcoholic steatohepatitis: common metabolic aspects of innate immune system and oxidative stress. Drug Metabol Pharmacokinet 2011;26:30\u201346. https:\/\/doi.org\/10.2133\/dmpk.dmpk-10-rv-087.","DOI":"10.2133\/dmpk.DMPK-10-RV-087"},{"key":"2025121209140770569_j_jcim-2021-0479_ref_004","doi-asserted-by":"crossref","unstructured":"Martel, C, Esposti, DD, Bouchet, A, Brenner, C, Lemoine, A. Non-alcoholic steatohepatitis: new insights from OMICS studies. Curr Pharmaceut Biotechnol 2012;13:726\u201335. https:\/\/doi.org\/10.2174\/138920112799857558.","DOI":"10.2174\/138920112799857558"},{"key":"2025121209140770569_j_jcim-2021-0479_ref_005","doi-asserted-by":"crossref","unstructured":"Yilmaz, Y, Yonal, O, Kurt, R, Alahdab, YO, Eren, F, Ozdogan, O, et al.. Serum\u00a0levels of omentin, chemerin and adipsin in patients with biopsy-proven nonalcoholic fatty liver disease. Scand J Gastroenterol 2011;46:91\u20137. https:\/\/doi.org\/10.3109\/00365521.2010.516452.","DOI":"10.3109\/00365521.2010.516452"},{"key":"2025121209140770569_j_jcim-2021-0479_ref_006","doi-asserted-by":"crossref","unstructured":"Manieri, E, Sabio, G. Stress kinases in the modulation of metabolism and energy balance. J Mol Endocrinol 2015;55:R11\u201322. https:\/\/doi.org\/10.1530\/jme-15-0146.","DOI":"10.1530\/JME-15-0146"},{"key":"2025121209140770569_j_jcim-2021-0479_ref_007","doi-asserted-by":"crossref","unstructured":"Gehart, H, Kumpf, S, Ittner, A, Ricci, R. MAPK signalling in cellular metabolism: stress or wellness? EMBO Rep 2010;11:834\u201340. https:\/\/doi.org\/10.1038\/embor.2010.160.","DOI":"10.1038\/embor.2010.160"},{"key":"2025121209140770569_j_jcim-2021-0479_ref_008","doi-asserted-by":"crossref","unstructured":"Bost, F, Aouadi, M, Caron, L, Bin\u00e9truy, B. The role of MAPKs in adipocyte differentiation and obesity. Biochimie 2005;87:51\u20136. https:\/\/doi.org\/10.1016\/j.biochi.2004.10.018.","DOI":"10.1016\/j.biochi.2004.10.018"},{"key":"2025121209140770569_j_jcim-2021-0479_ref_009","doi-asserted-by":"crossref","unstructured":"Liss, KHH, Finck, BN. PPARs and nonalcoholic fatty liver disease. Biochimie. 2017;136:65\u201374, https:\/\/doi.org\/10.1016\/j.biochi.2016.11.009.","DOI":"10.1016\/j.biochi.2016.11.009"},{"key":"2025121209140770569_j_jcim-2021-0479_ref_010","doi-asserted-by":"crossref","unstructured":"Kersten, S, Seydoux, J, Peters, JM, Gonzalez, FJ, Desvergne, B, Wahli, W. Peroxisome proliferator-activated receptor alpha mediates the adaptive response to fasting. J Clin Invest 1999;103:1489\u201398. https:\/\/doi.org\/10.1172\/jci6223.","DOI":"10.1172\/JCI6223"},{"key":"2025121209140770569_j_jcim-2021-0479_ref_011","doi-asserted-by":"crossref","unstructured":"Abdelmegeed, MA, Yoo, S-H, Henderson, LE, Gonzalez, FJ, Woodcroft, KJ, Song, B-J. PPARalpha expression protects male mice from high fat-induced nonalcoholic fatty liver. J Nutr 2011;141:603\u201310. https:\/\/doi.org\/10.3945\/jn.110.135210.","DOI":"10.3945\/jn.110.135210"},{"key":"2025121209140770569_j_jcim-2021-0479_ref_012","doi-asserted-by":"crossref","unstructured":"Stienstra, R, Duval, C, M\u00fcller, M, Kersten, S. PPARs, obesity, and inflammation. PPAR Res 2007;2007:95974.","DOI":"10.1155\/2007\/95974"},{"key":"2025121209140770569_j_jcim-2021-0479_ref_013","doi-asserted-by":"crossref","unstructured":"Zhang, H-A, Yang, X-Y, Xiao, Y-F. AMPK\u03b11 overexpression alleviates the hepatocyte model of nonalcoholic fatty liver disease via inactivating p38MAPK pathway. Biochem Biophys Res Commun. 2016;474:364\u201370, https:\/\/doi.org\/10.1016\/j.bbrc.2016.04.111.","DOI":"10.1016\/j.bbrc.2016.04.111"},{"key":"2025121209140770569_j_jcim-2021-0479_ref_014","doi-asserted-by":"crossref","unstructured":"Xu, H, Barnes, GT, Yang, Q, Tan, G, Yang, D, Chou, CJ, et al.. Chronic inflammation in fat plays a crucial role in the development of obesity-related insulin resistance. J Clin Invest 2003;112:1821\u201330. https:\/\/doi.org\/10.1172\/jci200319451.","DOI":"10.1172\/JCI200319451"},{"key":"2025121209140770569_j_jcim-2021-0479_ref_015","doi-asserted-by":"crossref","unstructured":"Weisberg, SP, McCann, D, Desai, M, Rosenbaum, M, Leibel, RL, Ferrante, AWJr. Obesity is associated with macrophage accumulation in adipose tissue. J Clin Invest 2003;112:1796\u2013808. https:\/\/doi.org\/10.1172\/jci200319246.","DOI":"10.1172\/JCI200319246"},{"key":"2025121209140770569_j_jcim-2021-0479_ref_016","unstructured":"Zeng, T, Zhu, L, Li, F, Yan, S, Ji, G, Zhang, L, et al.. Herbal Extracts and Natural Products in Alleviating Non-alcoholic Fatty Liver Disease via Activating Autophagy; 2018 Available from: www.frontiersin.org."},{"key":"2025121209140770569_j_jcim-2021-0479_ref_017","doi-asserted-by":"crossref","unstructured":"Harborne, JB. Indian medicinal plants. A compendium of 500 species. Vol. 1; edited by Warrier PK, Nambiar VPK, Ramankutty C. J Pharm Pharmacol 1994;46:935.","DOI":"10.1111\/j.2042-7158.1994.tb05722.x"},{"key":"2025121209140770569_j_jcim-2021-0479_ref_018","doi-asserted-by":"crossref","unstructured":"Wanjari, MM, Gangoria, R, Dey, YN, Gaidhani, SN, Pandey, NK, Jadhav, AD. Hepatoprotective and antioxidant activity of Bombax ceiba flowers against carbon tetrachloride-induced hepatotoxicity in rats. Hepatoma Res 2016;2:144. https:\/\/doi.org\/10.20517\/2394-5079.2015.55.","DOI":"10.20517\/2394-5079.2015.55"},{"key":"2025121209140770569_j_jcim-2021-0479_ref_019","doi-asserted-by":"crossref","unstructured":"Medhat, D, El-Bana, MA, El-Daly, SM, Ashour, MN, Elias, TR, Mohamed, RA, et al.. Influence of irisin on diet-induced metabolic syndrome in experimental rat model. J Compl Integr Med 2021;18:1\u20138. https:\/\/doi.org\/10.1515\/jcim-2020-0030.","DOI":"10.1515\/jcim-2020-0030"},{"key":"2025121209140770569_j_jcim-2021-0479_ref_020","doi-asserted-by":"crossref","unstructured":"Arafa, AF, Foda, DS, Mahmoud, AH, Metwally, NS, Farrag, ARH. Bombax ceiba flowers extract ameliorates hepatosteatosis induced by ethanol and relatively moderate fat diet in rats. Toxicol Rep 2019;6:401\u20138. https:\/\/doi.org\/10.1016\/j.toxrep.2019.04.008.","DOI":"10.1016\/j.toxrep.2019.04.008"},{"key":"2025121209140770569_j_jcim-2021-0479_ref_021","doi-asserted-by":"crossref","unstructured":"Matth\u00e4us, B. Antioxidant activity of extracts obtained from residues of different oilseeds. J Agric Food Chem 2002;50:3444\u201352. https:\/\/doi.org\/10.1021\/jf011440s.","DOI":"10.1021\/jf011440s"},{"key":"2025121209140770569_j_jcim-2021-0479_ref_022","doi-asserted-by":"crossref","unstructured":"Safwat, GM, Pisan\u00f2, S, D\u2019Amore, E, Borioni, G, Napolitano, M, Kamal, AA, et al.. Induction of non-alcoholic fatty liver disease and insulin resistance by feeding a high-fat diet in rats: does coenzyme Q monomethyl ether have a modulatory effect? Nutrition. 2009;25:1157\u201368, https:\/\/doi.org\/10.1016\/j.nut.2009.02.009.","DOI":"10.1016\/j.nut.2009.02.009"},{"key":"2025121209140770569_j_jcim-2021-0479_ref_023","doi-asserted-by":"crossref","unstructured":"Mustafa, MA, Ashry, M, Salama, HH, Abdelhamid, SM, Hassan, LK, Abdel-Wahhab, KG. Ameliorative role of ashwagandha\/probiotics fortified yogurt against AlCl3 toxicity in rats. Int J Dairy Sci 2020;15:169\u201381. https:\/\/doi.org\/10.3923\/ijds.2020.169.181.","DOI":"10.3923\/ijds.2020.169.181"},{"key":"2025121209140770569_j_jcim-2021-0479_ref_024","doi-asserted-by":"crossref","unstructured":"Matthews, DR, Hosker, JP, Rudenski, AS, Naylor, BA, Treacher, DF, Turner, RC. Homeostasis model assessment: insulin resistance and \u03b2-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 1985;28:412\u20139. https:\/\/doi.org\/10.1007\/bf00280883.","DOI":"10.1007\/BF00280883"},{"key":"2025121209140770569_j_jcim-2021-0479_ref_025","doi-asserted-by":"crossref","unstructured":"Hussein, J, Mostafa, E, El-Waseef, M, El-Khayat, Z, Badawy, E, Medhat, D. Effect of omega-3 fatty acids on erythrocyte membrane in diabetic rats. Macedonian J Med Sci 2011;4:234\u20139. https:\/\/doi.org\/10.3889\/mjms.1857-5773.2011.0180.","DOI":"10.3889\/MJMS.1857-5773.2011.0180"},{"key":"2025121209140770569_j_jcim-2021-0479_ref_026","unstructured":"Ahmadi, SA, Boroumand, MA, Gohari-Moghaddam, K, Tajik, P, Dibaj, SM. The impact of low serum triglyceride on LDL-cholesterol estimation. Arch Iran Med 2008;11:318\u201321."},{"key":"2025121209140770569_j_jcim-2021-0479_ref_045","doi-asserted-by":"crossref","unstructured":"Coulthard, LR, White, DE, Jones, DL, McDermott, MF, Burchill, SA. p38(MAPK): stress responses from molecular mechanisms to therapeutics. Trends Mol Med 2009;15:369\u201379. https:\/\/doi.org\/10.1016\/j.molmed.2009.06.005.","DOI":"10.1016\/j.molmed.2009.06.005"},{"key":"2025121209140770569_j_jcim-2021-0479_ref_030","doi-asserted-by":"crossref","unstructured":"Manco, M. Insulin resistance and NAFLD: a dangerous liaison beyond the genetics. Children 2017;4:74. https:\/\/doi.org\/10.3390\/children4080074.","DOI":"10.3390\/children4080074"},{"key":"2025121209140770569_j_jcim-2021-0479_ref_031","doi-asserted-by":"crossref","unstructured":"Shulman, GI. Ectopic fat in insulin resistance, dyslipidemia, and cardiometabolic disease. N Engl J Med 2014;371:1131\u201341. https:\/\/doi.org\/10.1056\/nejmra1011035.","DOI":"10.1056\/NEJMra1011035"},{"key":"2025121209140770569_j_jcim-2021-0479_ref_029","doi-asserted-by":"crossref","unstructured":"Angulo, P. Nonalcoholic fatty liver disease. N Engl J Med. 2002;346:1221\u201331, https:\/\/doi.org\/10.1056\/nejmra011775.","DOI":"10.1056\/NEJMra011775"},{"key":"2025121209140770569_j_jcim-2021-0479_ref_032","doi-asserted-by":"crossref","unstructured":"Ojeda, ML, Delgado-Villa, MJ, Llopis, R, Murillo, ML, Carreras, O. Lipid metabolism in ethanol-treated rat pups and adults: effects of folic acid. Alcohol Alcohol 2008;43:544\u201350. https:\/\/doi.org\/10.1093\/alcalc\/agn044.","DOI":"10.1093\/alcalc\/agn044"},{"key":"2025121209140770569_j_jcim-2021-0479_ref_033","doi-asserted-by":"crossref","unstructured":"Alter, R, de Luis, DA, Izaola, O, Sagrado, MG, Conde, R, Gago, TA, et al.. G308A polymorphism of TNF-alpha gene is associated with insulin resistance and histological changes in non alcoholic fatty liver disease patients. Ann Hepatol 2010;9:439\u201344. https:\/\/doi.org\/10.1016\/s1665-2681(19)31620-5.","DOI":"10.1016\/S1665-2681(19)31620-5"},{"key":"2025121209140770569_j_jcim-2021-0479_ref_034","doi-asserted-by":"crossref","unstructured":"Sazci, A, Akpinar, G, Aygun, C, Ergul, E, Senturk, O, Hulagu, S. Association of apolipoprotein E polymorphisms in patients with non-alcoholic steatohepatitis. Dig Dis Sci 2008;53:3218\u201324. https:\/\/doi.org\/10.1007\/s10620-008-0271-5.","DOI":"10.1007\/s10620-008-0271-5"},{"key":"2025121209140770569_j_jcim-2021-0479_ref_035","unstructured":"Kohan, L, Safarpur, M, Abdollahi, H. Omentin-1 rs2274907 and resistin rs1862513 polymorphisms influence genetic susceptibility to nonalcoholic fatty liver disease. Mol Biol Res Commun 2016;5:11\u20137."},{"key":"2025121209140770569_j_jcim-2021-0479_ref_036","doi-asserted-by":"crossref","unstructured":"Wang, J, Guo, X-F, Yu, S-J, Song, J, Zhang, J-X, Cao, Z, et al.. Adiponectin polymorphisms and non-alcoholic fatty liver disease risk: a meta-analysis. J Gastroenterol Hepatol 2014;29:1396\u2013405.","DOI":"10.1111\/jgh.12562"},{"key":"2025121209140770569_j_jcim-2021-0479_ref_037","doi-asserted-by":"crossref","unstructured":"Giannitrapani, L, Soresi, M, Balasus, D, Licata, A, Montalto, G. Genetic association of interleukin-6 polymorphism (-174 G\/C) with chronic liver diseases and hepatocellular carcinoma. World J Gastroenterol 2013;19:2449\u201355. https:\/\/doi.org\/10.3748\/wjg.v19.i16.2449.","DOI":"10.3748\/wjg.v19.i16.2449"},{"key":"2025121209140770569_j_jcim-2021-0479_ref_038","doi-asserted-by":"crossref","unstructured":"Yang, R-Z, Lee, M-J, Hu, H, Pray, J, Wu, H-B, Hansen, BC, et al.. Identification of omentin as a novel depot-specific adipokine in human adipose tissue: possible role in modulating insulin action. Am J Physiol Endocrinol Metab 2006;290:E1253\u201361. https:\/\/doi.org\/10.1152\/ajpendo.00572.2004.","DOI":"10.1152\/ajpendo.00572.2004"},{"key":"2025121209140770569_j_jcim-2021-0479_ref_039","doi-asserted-by":"crossref","unstructured":"Shibata, R, Ouchi, N, Takahashi, R, Terakura, Y, Ohashi, K, Ikeda, N, et al.. Omentin as a novel biomarker of metabolic risk factors. Diabetol Metab Syndrome 2012;4:37. https:\/\/doi.org\/10.1186\/1758-5996-4-37.","DOI":"10.1186\/1758-5996-4-37"},{"key":"2025121209140770569_j_jcim-2021-0479_ref_040","doi-asserted-by":"crossref","unstructured":"Suliga, E, Wawszczak, M, Gluszek, S. The roles of vaspin, chemerin, and omentin in the determination of metabolic syndrome. Med Stud 2018;34:160\u201377. https:\/\/doi.org\/10.5114\/ms.2018.76878.","DOI":"10.5114\/ms.2018.76878"},{"key":"2025121209140770569_j_jcim-2021-0479_ref_041","doi-asserted-by":"crossref","unstructured":"Ahmed, FG, Nearmeen, MR, Ebtesam, MI, Abomandour, HG, Hasan, MD. The association of serum omentin-1 levels with severity of nonalcoholic fatty liver disease in correlation with cardiovascular risk factors among Egyptian women. Med J Cairo Univ. 2019;87:1783\u201391, https:\/\/doi.org\/10.21608\/mjcu.2019.53966.","DOI":"10.21608\/mjcu.2019.53966"},{"key":"2025121209140770569_j_jcim-2021-0479_ref_042","doi-asserted-by":"crossref","unstructured":"Pan, HY, Guo, L, Li, Q. Changes of serum omentin-1 levels in normal subjects and in patients with impaired glucose regulation and with newly diagnosed and untreated type 2 diabetes. Diabetes Res Clin Pract 2010;88:29\u201333. https:\/\/doi.org\/10.1016\/j.diabres.2010.01.013.","DOI":"10.1016\/j.diabres.2010.01.013"},{"key":"2025121209140770569_j_jcim-2021-0479_ref_043","doi-asserted-by":"crossref","unstructured":"de Souza Batista, CM, Yang, R-Z, Lee, M-J, Glynn, NM, Yu, D-Z, Pray, J, et al.. Omentin plasma levels and gene expression are decreased in obesity. Diabetes 2007;56:1655. https:\/\/doi.org\/10.2337\/db06-1506.","DOI":"10.2337\/db06-1506"},{"key":"2025121209140770569_j_jcim-2021-0479_ref_044","doi-asserted-by":"crossref","unstructured":"Tan, BK, Adya, R, Farhatullah, S, Lewandowski, KC, O\u2019Hare, P, Lehnert, H, et al.. Omentin-1, a novel adipokine, is decreased in overweight insulin-resistant women with polycystic ovary syndrome. Diabetes 2008;57:801. https:\/\/doi.org\/10.2337\/db07-0990.","DOI":"10.2337\/db07-0990"},{"key":"2025121209140770569_j_jcim-2021-0479_ref_046","doi-asserted-by":"crossref","unstructured":"Sartori, R, Li, F, Kirkwood, KL. MAP kinase phosphatase-1 protects against inflammatory bone loss. J Dent Res 2009;88:1125\u201330. https:\/\/doi.org\/10.1177\/0022034509349306.","DOI":"10.1177\/0022034509349306"},{"key":"2025121209140770569_j_jcim-2021-0479_ref_047","doi-asserted-by":"crossref","unstructured":"Farley, N, Pedraza-Alva, G, Serrano-Gomez, D, Nagaleekar, V, Aronshtam, A, Krahl, T, et al.. p38 mitogen-activated protein kinase mediates the Fas-induced mitochondrial death pathway in CD8+ T\u00a0cells. Mol Cell Biol 2006;26:2118\u201329. https:\/\/doi.org\/10.1128\/mcb.26.6.2118-2129.2006.","DOI":"10.1128\/MCB.26.6.2118-2129.2006"},{"key":"2025121209140770569_j_jcim-2021-0479_ref_048","doi-asserted-by":"crossref","unstructured":"Carlson, CJ, Koterski, S, Sciotti, RJ, Poccard, GB, Rondinone, CM. Enhanced basal activation of mitogen-activated protein kinases in adipocytes from type 2 diabetes. Diabetes 2003;52:634. https:\/\/doi.org\/10.2337\/diabetes.52.3.634.","DOI":"10.2337\/diabetes.52.3.634"},{"key":"2025121209140770569_j_jcim-2021-0479_ref_049","doi-asserted-by":"crossref","unstructured":"Olefsky, JM, Glass, CK. Macrophages, inflammation, and insulin resistance. Annu Rev Physiol 2010;72:219\u201346. https:\/\/doi.org\/10.1146\/annurev-physiol-021909-135846.","DOI":"10.1146\/annurev-physiol-021909-135846"},{"key":"2025121209140770569_j_jcim-2021-0479_ref_050","doi-asserted-by":"crossref","unstructured":"Samuel, VT, Shulman, GI. Nonalcoholic fatty liver disease as a nexus of metabolic and hepatic diseases. Cell Metabol 2018;27:22\u201341. https:\/\/doi.org\/10.1016\/j.cmet.2017.08.002.","DOI":"10.1016\/j.cmet.2017.08.002"},{"key":"2025121209140770569_j_jcim-2021-0479_ref_051","doi-asserted-by":"crossref","unstructured":"Boutros, T, Chevet, E, Metrakos, P. Mitogen-activated protein (MAP) kinase\/MAP kinase phosphatase regulation: roles in cell growth, death, and cancer. Pharmacol Rev 2008;60:261. https:\/\/doi.org\/10.1124\/pr.107.00106.","DOI":"10.1124\/pr.107.00106"},{"key":"2025121209140770569_j_jcim-2021-0479_ref_052","doi-asserted-by":"crossref","unstructured":"Caunt, CJ, Keyse, SM. Dual-specificity MAP kinase phosphatases (MKPs): shaping the outcome of MAP kinase signalling. FEBS J 2013;280:489\u2013504. https:\/\/doi.org\/10.1111\/j.1742-4658.2012.08716.x.","DOI":"10.1111\/j.1742-4658.2012.08716.x"},{"key":"2025121209140770569_j_jcim-2021-0479_ref_053","doi-asserted-by":"crossref","unstructured":"Patsouris, D, Reddy, JK, M\u00fcller, M, Kersten, S. Peroxisome proliferator-activated receptor \u03b1 mediates the effects of high-fat diet on hepatic gene expression. Endocrinology 2006;147:1508\u201316. https:\/\/doi.org\/10.1210\/en.2005-1132.","DOI":"10.1210\/en.2005-1132"},{"key":"2025121209140770569_j_jcim-2021-0479_ref_054","doi-asserted-by":"crossref","unstructured":"Abdelsayed, EM, Medhat, D, Mandour, YM, Hanafi, RS, Motaal, AA. Niazimicin: a thiocarbamate glycoside from Moringa oleifera Lam. seeds with a novel neuroprotective activity. J Food Biochem 2021. https:\/\/doi.org\/10.1111\/jfbc.13992.","DOI":"10.1111\/jfbc.13992"},{"key":"2025121209140770569_j_jcim-2021-0479_ref_055","doi-asserted-by":"crossref","unstructured":"Elshamy, S, Abdel Motaal, A, Abdel-Halim, M, Medhat, D, Handoussa, H. Potential neuroprotective activity of Mentha longifolia L. in aluminum chloride-induced rat model of Alzheimer\u2019s disease. J Food Biochem. 2021;1\u201313, https:\/\/doi.org\/10.1111\/jfbc.13644.","DOI":"10.1111\/jfbc.13644"},{"key":"2025121209140770569_j_jcim-2021-0479_ref_056","doi-asserted-by":"crossref","unstructured":"Aziz, S, Ahmed, S, Lisa, SA, Parvin, T. Analysis of fatty acid and determination of total protein, alkaloid, saponin , flavonoid of Bangladeshi Bombax ceiba Linn leaves and seeds. IJPBR 2017;4:23\u20138.","DOI":"10.30750\/ijpbr.4.4.6"},{"key":"2025121209140770569_j_jcim-2021-0479_ref_057","doi-asserted-by":"crossref","unstructured":"Chen, J, Zhuang, D, Cai, W, Xu, L, Li, E, Wu, Y, et al.. Inhibitory effects of four plants flavonoids extracts on fatty acid synthase. J Environ Sci. 2009;21:S131\u20134, https:\/\/doi.org\/10.1016\/s1001-0742(09)60056-5.","DOI":"10.1016\/S1001-0742(09)60056-5"},{"key":"2025121209140770569_j_jcim-2021-0479_ref_058","doi-asserted-by":"crossref","unstructured":"Gupta, P, Goyal, R, Chauhan, Y, Sharma, PL. Possible modulation of FAS and PTP-1B signaling in ameliorative potential of Bombax ceiba against high fat diet induced obesity. BMC Complement Altern Med 2013;25:281.","DOI":"10.1186\/1472-6882-13-281"},{"key":"2025121209140770569_j_jcim-2021-0479_ref_059","unstructured":"Said AAboutabl, AHE, Nofal, SM, Tokuda, H, Raslan, M. Phytoconstituents and bioctivity evaluation of Bombax ceiba L. J Tradit Med 2011;28:55\u201362."},{"key":"2025121209140770569_j_jcim-2021-0479_ref_060","doi-asserted-by":"crossref","unstructured":"Ezzat, SM, El Bishbishy, MH, Aborehab, NM, Salama, MM, Hasheesh, A, Motaal, AA, et al.. Upregulation of MC4R and PPAR-\u03b1 expression\u00a0mediates the anti-obesity activity of Moringa oleifera Lam. in high-fat diet-induced obesity in rats. J Ethnopharmacol 2020;251:112541. https:\/\/doi.org\/10.1016\/j.jep.2020.112541.","DOI":"10.1016\/j.jep.2020.112541"},{"key":"2025121209140770569_j_jcim-2021-0479_ref_061","doi-asserted-by":"crossref","unstructured":"Bhalla, US, Ram, PT, Iyengar, R. MAP kinase phosphatase as a locus of flexibility in a mitogen-activated protein kinase signaling network. Science 2002;297:1018. https:\/\/doi.org\/10.1126\/science.1068873.","DOI":"10.1126\/science.1068873"},{"key":"2025121209140770569_j_jcim-2021-0479_ref_062","doi-asserted-by":"crossref","unstructured":"Lawan, A, Bennett, AM. Mitogen-activated protein kinase regulation in hepatic metabolism. Trends Endocrinol Metab. 2017;28:868\u201378, https:\/\/doi.org\/10.1016\/j.tem.2017.10.007.","DOI":"10.1016\/j.tem.2017.10.007"},{"key":"2025121209140770569_j_jcim-2021-0479_ref_063","doi-asserted-by":"crossref","unstructured":"Mahmoodi, M, Hosseini, R, Kazemi, A, Ofori-Asenso, R, Mazidi, M, Mazloomi, SM. Effects of green tea or green tea catechin on liver enzymes in healthy individuals and people with nonalcoholic fatty liver disease: a systematic review and meta-analysis of randomized clinical trials. Phytother Res 2020;34:1587\u201398. https:\/\/doi.org\/10.1002\/ptr.6637.","DOI":"10.1002\/ptr.6637"},{"key":"2025121209140770569_j_jcim-2021-0479_ref_064","doi-asserted-by":"crossref","unstructured":"Zhang, C, Hu, J, Sheng, L, Yuan, M, Wu, Y, Chen, L, et al.. Ellagic acid ameliorates AKT-driven hepatic steatosis in mice by suppressing de novo lipogenesis via the AKT\/SREBP-1\/FASN pathway. Food Funct 2019;10:3410\u201320. https:\/\/doi.org\/10.1039\/c9fo00284g.","DOI":"10.1039\/C9FO00284G"},{"key":"2025121209140770569_j_jcim-2021-0479_ref_065","doi-asserted-by":"crossref","unstructured":"Tanaka, M, Sato, A, Kishimoto, Y, Mabashi-Asazuma, H, Kondo, K, Iida, K. Gallic acid inhibits lipid accumulation via AMPK pathway and suppresses apoptosis and macrophage-mediated inflammation in hepatocytes. Nutrients 2020;12:1479. https:\/\/doi.org\/10.3390\/nu12051479.","DOI":"10.3390\/nu12051479"},{"key":"2025121209140770569_j_jcim-2021-0479_ref_066","doi-asserted-by":"crossref","unstructured":"Shi, A, Li, T, Zheng, Y, Song, Y, Wang, H, Wang, N, et al.. Chlorogenic acid improves NAFLD by regulating gut microbiota and GLP-1. Front Pharmacol 2021;12:1648. https:\/\/doi.org\/10.3389\/fphar.2021.693048.","DOI":"10.3389\/fphar.2021.693048"},{"key":"2025121209140770569_j_jcim-2021-0479_ref_067","doi-asserted-by":"crossref","unstructured":"Mu, H-N, Zhou, Q, Yang, R-Y, Tang, W-Q, Li, H-X, Wang, S-M, et al.. Caffeic acid prevents non-alcoholic fatty liver disease induced by a high-fat diet through gut microbiota modulation in mice. Food Res Int. 2021;143:110240, https:\/\/doi.org\/10.1016\/j.foodres.2021.110240.","DOI":"10.1016\/j.foodres.2021.110240"},{"key":"2025121209140770569_j_jcim-2021-0479_ref_068","doi-asserted-by":"crossref","unstructured":"Saha, P, Das, TA, Nath, R, Sarker, SD, Nahar, L, Sahu, J, et al.. Role of natural phenolics in hepatoprotection: a mechanistic review and analysis of regulatory network of associated genes. Front Pharmacol 2019;10:509. https:\/\/doi.org\/10.3389\/fphar.2019.00509.","DOI":"10.3389\/fphar.2019.00509"}],"container-title":["Journal of Complementary and Integrative Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.degruyterbrill.com\/document\/doi\/10.1515\/jcim-2021-0479\/xml","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.degruyterbrill.com\/document\/doi\/10.1515\/jcim-2021-0479\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,12]],"date-time":"2025-12-12T11:51:47Z","timestamp":1765540307000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.degruyterbrill.com\/document\/doi\/10.1515\/jcim-2021-0479\/html"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,3,21]]},"references-count":66,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2022,10,31]]},"published-print":{"date-parts":[[2023,6,15]]}},"alternative-id":["10.1515\/jcim-2021-0479"],"URL":"https:\/\/doi.org\/10.1515\/jcim-2021-0479","relation":{},"ISSN":["1553-3840"],"issn-type":[{"value":"1553-3840","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,3,21]]}}}